Breast Radiotherapy: Less is More?

Clinical Oncology

Volumn 25, Issue 2, 2013, Pages 127-134

  Coles, C E ^a   Brunt, A M ^b   Wheatley, D ^c   Mukesh, M B ^a   Yarnold, J R ^d  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^c ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast cancer; Clinical trials; Radiotherapy

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; FEMALE; HISTORY OF MEDICINE; HUMAN; MEDICAL INFORMATION; METHODOLOGY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT;

BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; RADIOTHERAPY, ADJUVANT;

EID: 84872413915     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.10.013     Document Type: Article

References (45)

1. Williams M. Inappropriate use of linear-quadratic analysis of tumor response. Int J Radiat Oncol Biol Phys 1985, 11. 1570-3P6.
2. Douglas B.G. Superfractionation: its rationale and anticipated benefits. Int J Radiat Oncol Biol Phys 1982, 8:1143-1153.
3. Cohen L. Radiotherapy in breast cancer. I. The dose-time relationship theoretical considerations. Br J Radiol 1952, 25:636-642.
4. Yarnold J., Bentzen S.M., Coles C., Haviland J. Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities. Int J Radiat Oncol Biol Phys 2011, 79:1-9.
5. Bates T., Evans R.G.B. Report of the independent review commissioned by the Royal College of Radiologists into brachial plexus neuropathy following radiotherapy for breast carcinoma 1995, Royal College of Radiologists, London.
6. Whelan T.J., Pignol J.P., Levine M.N., et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010, 362:513-520.
7. Owen J.R., Ashton A., Bliss J.M., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006, 7:467-471.
8. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005, 75:9-17.
9. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008, 9:331-341.
10. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008, 371:1098-1107.
11. James ML, Lehman M, Hider PN, Jeffery M, Francis DP, Hickey BE. Fraction size for radiation treatment for breast conservation in early breast cancer. Cochrane Database of Systematic Reviews 2008.
12. James ML, Lehman M, Hider PN, Jeffery M, Hickey BE, Francis DP. Fraction size in radiation treatment for breast conservation in early breast cancer. Cochrane Database of Systematic Reviews 2010:CD003860.
13. NICE Early and locally advanced breast cancer: diagnosis and treatment 2009, NICE Guidelines.
14. Haviland J.S., Yarnold J.R., Bentzen S.M. Hypofractionated radiotherapy for breast cancer. N Engl J Med 2010, 362:1843. author reply 43-44.
15. Darby S.C., Cutter D.J., Boerma M., et al. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys 2010, 76:656-665.
16. Turesson I. The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships. Radiother Oncol 1989, 15:217-226.
17. Courdi A., Ortholan C., Hannoun-Levi J.M., et al. Long-term results of hypofractionated radiotherapy and hormonal therapy without surgery for breast cancer in elderly patients. Radiother Oncol 2006, 79:156-161.
18. Kirova Y.M., Campana F., Savignoni A., et al. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy. Int J Radiat Oncol Biol Phys 2009, 75:76-81.
19. Agrawal R.K., Alhasso A., Barrett-Lee P.J., et al. First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015). Radiother Oncol 2011, 100:93-100.
20. Huang J., Barbera L., Brouwers M., Browman G., Mackillop W.J. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003, 21:555-563.
21. Hebert-Croteau N., Freeman C.R., Latreille J., Brisson J. Delay in adjuvant radiation treatment and outcomes of breast cancer - a review. Breast Cancer Res Treat 2002, 74:77-94.
22. Martin S., Mannino M., Rostom A., et al. Acute toxicity and 2-year adverse effects of 30 Gy in five fractions over 15 days to whole breast after local excision of early breast cancer. Clin Oncol (R Coll Radiol) 2008, 20:502-505.
23. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007, 25:3259-3265.
24. Harrington K.J., Harrison M., Bayle P., et al. Surgical clips in planning the electron boost in breast cancer: a qualitative and quantitative evaluation. Int J Radiat Oncol Biol Phys 1996, 34:579-584.
25. Krawczyk J.J., Engel B. The importance of surgical clips for adequate tangential beam planning in breast conserving surgery and irradiation. Int J Radiat Oncol Biol Phys 1999, 43:347-350.
26. Surgical guidelines for the management of breast cancer. Eur J Surg Oncol 2009, 35(Suppl. 1):1-22.
27. Donovan E.M., Ciurlionis L., Fairfoul J., et al. Planning with intensity-modulated radiotherapy and tomotherapy to modulate dose across breast to reflect recurrence risk (IMPORT High trial). Int J Radiat Oncol Biol Phys 2011, 79:1064-1072.
28. Askoxylakis V., Jensen A.D., Hafner M.F., et al. Simultaneous integrated boost for adjuvant treatment of breast cancer - intensity modulated vs. conventional radiotherapy: the IMRT-MC2 trial. BMC Cancer 2011, 11:249.
29. Higher-dose radiation therapy or standard radiation therapy in treating patients with early-stage breast cancer that was removed by surgery. Available at:. http://clinicaltrials.gov/ct2/show/NCT01349322.
30. Coles C.E., Harris E.J., Donovan E.M., et al. Evaluation of implanted gold seeds for breast radiotherapy planning and on treatment verification: a feasibility study on behalf of the IMPORT trialists. Radiother Oncol 2011, 100:276-281.
31. Collette S., Collette L., Budiharto T., et al. Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'. Eur J Cancer 2008, 44:2587-2599.
32. Vrieling C., Collette L., Fourquet A., et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 2000, 55:219-232.
33. Polgar C., Fodor J., Major T., et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma - 5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 2007, 69:694-702.
34. Strnad V, Polgar C. On behalf of the European Brachytherapy Breast Cancer GEC-ESTRO Working Group. GEC-ESTRO APBI Trial: Interstitial brachytherapy alone versus external beam radiation therapy after breast conserving surgery for low risk invasive carcinoma and low risk duct carcinoma in-situ (DCIS) of the female breast. 2006. Available at:. http://www.apbi.uni-erlangen.de/outline/outline.html.
35. Wolmark N, Curran W. On behalf of NSABP and RTOG of the American College of Radiology (ACR). NSABP Protocol B-39. RTOG Protocol 0413. A randomized phase III study of conventional whole breast irradiation versus partial breast irradiation for women with stage 0, I, or II breast cancer. National Surgical Adjuvant Breast and Bowel Project (NSABP). Trial protocol 13 March 2007, pp. 1-132. Available at:. http://clinicaltrials.gov/ct2/show/NCT00103181.
36. Ontario Clinical Oncology Group (OCOG), Canadian Institutes of Health Research (CIHR), Canadian Breast Cancer Research Alliance. RAPID: Randomized Trial of Accelerated Partial Breast Irradiation, 2008. Available at:. http://clinicaltrials.gov/ct2/show/NCT00282035.
37. http://groups.eortc.be/radio/res/irma/synopsis_trial_irma1.pdf.
38. Belkacemi Y, Lartigau E. On behalf of Federation Nationale des Centres de Lutte Contre le Cancer. Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast Cancer (SHARE), 2010. Available at:. http://clinicaltrials.gov/ct2/show/NCT01247233.
39. Julian T.B., Costantino J.P., Vicini F.A., White J.R., Winter K.A. Early toxicity results with 3-D conformal external beam therapy (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial. Int J Radiat Oncol Biol Phys 2011, 8(2):S7.
40. Mukesh M., Harris E., Jena R., Evans P., Coles C. Relationship between irradiated breast volume and late normal tissue complications: a systematic review. Radiother Oncol 2012 Jul, 104(1):1-10.
41. Vaidya J.S., Joseph D.J., Tobias J.S., et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 2010, 376:91-102.
42. Nuyten D.S., Kreike B., Hart A.A., et al. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 2006, 8:R62.
43. Belletti B., Vaidya J.S., D'Andrea S., et al. Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin Cancer Res 2008, 14:1325-1332.
44. Orecchia R., Ciocca M., Lazzari R., et al. Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. Breast 2003, 12:483-490.
45. Veronesi U., Orecchia R., Luini A., et al. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat 2010, 124:141-151.